Psoriasis pathogenesis and the development of novel targeted immune therapies
Top Cited Papers
Open Access
- 1 September 2017
- journal article
- review article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 140 (3), 645-653
- https://doi.org/10.1016/j.jaci.2017.07.004
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Generation of pathogenic TH17 cells in the absence of TGF-β signallingNature, 2010
- Effector and Regulatory T-cell Subsets in Autoimmunity and Tissue InflammationScandinavian Journal of Immunology, 2010
- A Disintegrin-like and Metalloprotease (Reprolysin-type) with Thrombospondin Type 1 Motif (ADAMTS) Superfamily: Functions and MechanismsJournal of Biological Chemistry, 2009
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis PathogenesisJournal of Investigative Dermatology, 2009
- Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8The Journal of Experimental Medicine, 2009
- PsoriasisNew England Journal of Medicine, 2009
- Angiogenesis drives psoriasis pathogenesisInternational Journal of Experimental Pathology, 2009
- Resident and “Inflammatory” Dendritic Cells in Human SkinJournal of Investigative Dermatology, 2009
- The Risk of Mortality in Patients With PsoriasisArchives of Dermatology, 2007
- Antimicrobial peptides of multicellular organismsNature, 2002